ConductScience.org, home

Paper · 422250

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,321,428THE HEAT-LABILE SERUM FACTOR ASSOCIATED WITH INTRACELLULAR KILLING OF STAPHYLOCOCCUS AUREUS.J Immunol1965https://conductscience.org/library/papers/14321428PubMed
214,079,018THE CHEMICAL BASIS OF THE VIRULENCE OF BACILLUS ANTHRACIS. IX. ITS AGGRESSINS AND THEIR MODE OF ACTION.Br J Exp Pathol1963https://conductscience.org/library/papers/14079018PubMed
314,461,914Current knowledge of type-specific M antigens of group A streptococci.J Immunol1962https://conductscience.org/library/papers/14461914PubMed
433,904Pneumococcal adherence to human epithelial cells.Infect Immun1979https://conductscience.org/library/papers/33904PubMed
5352,958Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.Infect Immun1978https://conductscience.org/library/papers/352958PubMed
6641,141The key role of peptidoglycan in the opsonization of Staphylococcus aureus.J Clin Invest1978https://conductscience.org/library/papers/641141PubMed
7640,738Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.Infect Immun1978https://conductscience.org/library/papers/640738PubMed
8608,687Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.Immunology1977https://conductscience.org/library/papers/608687PubMed
9886,206The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.J Infect Dis1977https://conductscience.org/library/papers/886206PubMed
10860,727Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.Am J Med1977https://conductscience.org/library/papers/860727PubMed
114,854,538Surface polysaccharide from Staphylococcus aureus M that contains taurine, D-aminogalacturonic acid, and D-fucosamine.J Bacteriol1974https://conductscience.org/library/papers/4854538PubMed
124,120,360Phagocytosis as a surface phenomenon. II. Contact angles and phagocytosis of encapsulated bacteria before and after opsonization by specific antiserum and complement.J Reticuloendothel Soc1972https://conductscience.org/library/papers/4120360PubMed
134,173,341Immunochemical studies on the cross-reactivity between streptococcal and staphylococcal mucopeptide.J Exp Med1968https://conductscience.org/library/papers/4173341PubMed
144,604,161Biological properties of the encapsulated Staphylococcus aureus M.Infect Immun1974https://conductscience.org/library/papers/4604161PubMed
1552,236Immunological activity of the peptidoglycan.Z Immunitatsforsch Exp Klin Immunol1975https://conductscience.org/library/papers/52236PubMed
164,594,162Phagocytosis (third of three parts).N Engl J Med1974https://conductscience.org/library/papers/4594162PubMed
17162,811Phagocytosis: recognition and ingestion.Semin Hematol1975https://conductscience.org/library/papers/162811PubMed
184,800,534Role of electric surface charge of cell membrane in phagocytosis.Acta Pathol Jpn1973https://conductscience.org/library/papers/4800534PubMed
194,950,867The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.Immunology1971https://conductscience.org/library/papers/4950867PubMed
201,254,970Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis.J Immunol1976https://conductscience.org/library/papers/1254970PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/422250/references